1 0 9 Epidemic C. difficile (027/BI/NAP1) has rapidly emerged in the past decade as the leading cause of antibiotic-associated diarrhea worldwide. However, the key events in evolutionary history leading to its emergence and the subsequent patterns of global spread remain unknown. Here, we define the global population structure of C. difficile 027/BI/NAP1 using whole-genome sequencing and phylogenetic analysis. We show that two distinct epidemic lineages, FQR1 and FQR2, not one as previously thought, emerged in North America within a relatively short period after acquiring the same fluoroquinolone resistance-conferring mutation and a highly related conjugative transposon. The two epidemic lineages showed distinct patterns of global spread, and the FQR2 lineage spread more widely, leading to healthcare-associated outbreaks in the UK, continental Europe and Australia. Our analysis identifies key genetic changes linked to the rapid transcontinental dissemination of epidemic C. difficile 027/BI/NAP1 and highlights the routes by which it spreads through the global healthcare system.
l e t t e r s of the genome). Of these SNPs, 3,150 (85%) were clustered and private to 8 individual isolates, suggesting that these genomic regions were imported from outside the 027/BI/NAP1 lineage ( Supplementary  Fig. 1 and Supplementary Note) . These SNPs were removed, as they could mask the true phylogenetic signal, leaving 536 SNPs for downstream phylogenetic analysis. Other than these import events, homologous recombination has not had a major role in shaping the phylogeny of the global C. difficile 027/BI/NAP1 collection ( Supplementary Fig. 2 and Supplementary Note) .
We generated a maximum-likelihood phylogeny representing the C. difficile 027/BI/NAP1 global population structure (Fig. 1a) . The phylogeny discriminates between >100 distinct genotypes within the global collection and shows limited geographic clustering, implying frequent long-range transmission among humans and, in a limited number of cases, two-way transmission between humans and animals or food sources (Supplementary Note). The core genome of C. difficile 027/BI/NAP1 exhibits a relatively low level of genetic diversity, consistent with its recent emergence, with very few SNPs defining the major branches in the phylogeny (Supplementary Fig. 3 ). Using three methods, we estimated the mutation rate of C. difficile 027/BI/ NAP1 to be between 1.47 × 10 −7 and 5.33 × 10 −7 (95% confidence interval) substitutions per site per year, equivalent to 1-2 mutations per genome per year ( Supplementary Fig. 4 , Supplementary Table 2 and Supplementary Note). This rate is ~10 times slower than those observed in Streptococcus pneumoniae 17 and Staphylococcus aureus 18 over similar timescales, possibly owing to the fact that metabolically dormant spores do not accumulate mutations 19 .
Notably, the global phylogeny shows the presence of two genetically distinct lineages, which have independently acquired an identical mutation (encoding a p.Thr82Ile alteration) in the DNA gyrase subunit A gene gyrA by either mutation or recombination, leading to high-level fluoroquinolone resistance 20 (Fig. 1) . Although both lineages share this mutation, the independent emergence of both lineages is highly supported by maximum-likelihood and Bayesian methods ( Supplementary Figs. 3 and 5) , unequivocally demonstrating that fluoroquinolone resistance has arisen in two epidemic C. difficile 027/BI/NAP1 lineages in two separate events. We named these two lineages FQR1 and FQR2. Bayesian analysis estimated that FQR1 and FQR2 emerged recently, with the most recent common ancestors appearing in ~1993 and ~1994, respectively (median estimates of 95% highest posterior density intervals were 1984-1999 for FQR1 and 1986-1999 for FQR2). Near the base of the C. difficile 027/BI/NAP1 phylogeny and outside of both FQR lineages are isolates from various global locations (Singapore, Japan, South Korea, Canada, the United States, the UK, Germany and France) and sampling times (1985-2009). To our knowledge, none of the isolates npg l e t t e r s in this part of the phylogeny are associated with major hospital outbreaks, suggesting that these isolates represent the pre-epidemic C. difficile 027/BI/NAP1 genetic background from which FQR epidemic lineages emerged.
The 7 and isolates associated with sporadic infections in South Korea 21 and Switzerland between 2007 and 2010. Bayesian phylogeographic analysis 22 indicated that the FQR1 lineage originated in the United States (99% probability). The earliest isolate in the FQR1 lineage is from Pittsburgh, Pennsylvania, in 2001, representing one of the earliest reports of an increase in CDI caused by FQR C. difficile 027/BI/NAP1 (refs. 9,23). Thus, FQR1 seems to represent an epidemic lineage that originally emerged in the northeastern United States and was subsequently transmitted to South Korea and Switzerland.
The FQR2 lineage contains the majority of epidemic isolates that show widespread geographic distribution (Fig. 1a) . The most notable feature in the FQR2 phylogeny is a star-like topology in the early part of the lineage, which is generally consistent with rapid population expansion from a common progenitor ( Supplementary Fig. 5 ). Two isolates in our collection were found on the node at the base of the star-like topology, one associated with an outbreak in Montreal in 2003 (ref. 24) and the other (with uncertain association with outbreak) from The Netherlands in 2006. Bayesian analysis suggested that the FQR2 lineage also originated in North America (59% probability of the United States and 33% probability of Canada). Notably, all but one Canadian isolate found in this lineage were from Montreal, where FQR C. difficile 027/BI/NAP1 outbreaks were initially reported in Canada 8, 10 .
The Bayesian phylogeny 25 contains multiple highly supported sublineages of FQR2 associated with distinct geographic locations, suggesting rapid transcontinental dissemination from North America to continental Europe, the UK and Australia. Our analysis shows a single introduction of FQR2 into Australia and at least four separate introductions into continental Europe, including two trans-Atlantic transmission events (one of which reached The Netherlands) and two from the UK, giving rise to present-day isolates in Austria and Poland 26 ( Fig. 2a and Supplementary Fig. 5) . Similarly, the descendants of the FQR2 lineage were introduced into the UK on at least four occasions, including three trans-Atlantic transmission events from North America and one from continental Europe, leading to a series of highly publicized outbreaks in UK hospitals from 2004 to 2006 (ref. 27) .
To investigate the introduction and subsequent spread of C. difficile 027/BI/NAP1 within the UK, we analyzed the genomes of a collection of 145 additional UK isolates from healthcare patients ( Supplementary Table 3 ) (in addition to the 43 UK isolates in our global collection). The maximum-likelihood phylogeny of these isolates (Fig. 1b) shows that long-range geographic transmission was frequent and extensive within the UK (Fig. 2b) . This collection confirms that FQR2 C. difficile 027/BI/NAP1 probably reached the UK on at least four separate occasions, arriving independently in Exeter, Ayrshire and Birmingham from North America and arriving in Maidstone from continental Europe (Figs. 1b and 2b) . Its introduction into the Maidstone area likely triggered a large-scale hospital outbreak that affected London and Cambridge 27 . Despite multiple introductions, the majority of present-day UK isolates (including those from Liverpool, Belfast, Birmingham, London, Cambridge, Exeter and multiple sites in Scotland) are descendants of one sublineage whose earliest representative in our collection is a 2002 Birmingham isolate. This dominant sublineage also underlies the Stoke Mandeville outbreak 27 (Figs. 1b and 2b) .
The emergence of epidemic C. difficile 027/BI/NAP1 has been proposed to be due to genetic changes in the tcdC gene of the PaLoc 4,7,8,28 . However, we discovered only two SNPs in the entire 19.6-kb PaLoc region in our 027/BI/NAP1 collection, both private to a single isolate. Consistent with a previous proposal based on two C. difficile 027/BI/NAP1 genomes 16 , there was no change within the entire PaLoc region between pre-and post-epidemic isolates of C. difficile 027/BI/NAP1 that could explain the emergence of the epidemic strains (Supplementary Note). We provide strong evidence that the acquisition of fluoroquinolone resistance in two distinct lineages is associated with the emergence of C. difficile 027/BI/NAP1. We next determined whether there were other genetic changes linked to the Fig. 5 ) and maximum-likelihood phylogeny (Fig. 1b) .
npg l e t t e r s acquisition of fluoroquinolone resistance that could underlie a presumed increase in fitness, contributing to the emergence of the FQR1 and FQR2 lineages. Only two and seven SNPs defined the branches leading to lineages FQR1 and FQR2, respectively. However, besides the gyrA mutation ( Fig. 1) , there were no SNPs shared by both lineages ( Supplementary Table 4 ). Furthermore, there was little evidence that a substantial change in phenotype could result from any of the SNPs that define the FQR1 and FQR2 lineages ( Supplementary  Table 4 and Supplementary Note), except perhaps the gyrA mutation itself. Besides these SNPs and the gyrA mutation, we also identified ten nonsynonymous SNPs conflicting with the phylogeny (homoplasic; 1.9% of the total number) that are present mainly within the FQR1 and FQR2 lineages. These ten SNPs affect eight genes associated with antimicrobial resistance or cell surface modification (Table 1,  Supplementary Fig. 3 and Supplementary Note) . However, these SNPs are only present within a small fraction of the FQR1 and FQR2 isolates, meaning that their presence cannot explain the emergence of C. difficile 027/BI/NAP1. Horizontal gene transfer is a key mechanism driving C. difficile evolution 29, 30 . We therefore assembled the C. difficile 027/BI/NAP1 genomes and identified widespread acquisition of a range of mobile elements associated with erythromycin, chloramphenicol, tetracycline and aminoglycoside resistance throughout the phylogeny (Supplementary Fig. 3 and Supplementary Note) . Notably, we found a class of CTn5-like elements 29 in almost all isolates in the FQR1 and FQR2 lineages, where they are inserted in the same genome location in the majority of isolates ( Supplementary Fig. 6 and Supplementary  Note) . The FQR1 and FQR2 lineages both share a common CTn5-like element, which we named Tn6192, which contains genes encoding an ABC transport system, a two-component transcriptional regulator and a predicted DNA-binding protein (Supplementary Table 5 ). The version found in the FQR2 lineage differs from that in the FQR1 lineage by harboring a contiguous insertion of 15.7 kb in length, Tn6105 (ref. 31) , which contains 14 genes, 4 of which are predicted to be DNA-binding proteins or transcriptional regulators ( Supplementary  Table 5 ). This element has also acted as a hotspot for further integrations throughout the FQR2 lineage (Supplementary Fig. 6) . The presence of Tn6192 is the only other shared genetic trait, aside from the fluoroquinolone resistance-conferring SNP, that differentiates the FQR1 and FQR2 lineages from the pre-epidemic isolates ( Supplementary Table 6 ). It is unknown whether the genes carried by this element have any phenotypic effect on the core genome. However, Tn6192 may have had a role in the success of these lineages.
We show that the separate acquisitions of fluoroquinolone resistance and a conjugative transposon in two distinct lineages of C. difficile 027/BI/NAP1 are the key genetic changes linked to its rapid emergence during the early 2000s 7, 8 . Furthermore, our data suggest that the acquisition of resistance to commonly used antibiotics is a major feature of the continued evolution and persistence of C. difficile 027/BI/NAP1 in healthcare settings. It is notable that fluoroquinolone antibiotics were one of the most commonly prescribed antibiotic classes in North America during the late 1990s and early 2000s 32 , such that it is during this time that selective pressure for the acquisition and maintenance of fluoroquinolone resistance within healthcare settings would have been at its highest, explaining the nearsimultaneous emergence of more than one clone of FQR C. difficile 027/BI/NAP1. We also demonstrate the ease and rapidity with which FQR C. difficile 027/BI/NAP1 has been transmitted internationally, highlighting the interconnectedness of the global healthcare system, which is facilitated by rapid human travel. Whole-genome sequencing and phylogenetic analysis has been used successfully for clinical transmission studies of methicillin-resistant S. aureus within a hospital 33 , and, although the low mutation rate of C. difficile might pose some limitations, we believe that this approach will have great potential for the study of C. difficile. Our analysis provides a genomic framework for understanding the population structure, geographic source, epidemiology and evolution of this highly transmissible healthcareassociated pathogen.
URLs. Path-O-Gen, http://tree.bio.ed.ac.uk/software/pathogen/.
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